Literature DB >> 9362371

Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat.

F Holzinger1, C D Schteingart, H T Ton-Nu, S A Eming, M J Monte, L R Hagey, A F Hofmann.   

Abstract

Studies were performed to characterize hepatic and intestinal transport, as well as biotransformation during transport, of a spectrum of fluorescent bile acids containing a fluorophore attached to the side chain. The following two classes of compounds were studied: 1) aminofluorescein (amF) coupled directly to the carboxylic group of a bile acid which was cholic, ursodeoxycholic, or cholylglycine; and 2) nitrobenzoxadiazolyl (NBD) coupled to the epsilon-amino group of a lysine conjugated bile acid, which was cholic or ursodeoxycholic. Fluorescein, a cholephilic organic anion, was studied as a control. Fluorescent bile acids were synthesized and their structures confirmed by nuclear magnetic resonance and mass spectrometry. Using the biliary fistula rat, hepatic transport, biotransformation, and choleretic activity were defined; intestinal absorption was assessed by jejunal or ileal perfusion studies. All fluorescent bile acids had hepatic transport maxima about one-sixth that reported for cholyltaurine, but derivatives of cholylglycine were transported best. Bile acids underwent little (<5%) biotransformation during hepatocyte transport. Only the amF conjugate of cholylglycine had normal choleretic activity; other compounds were hypocholeretic or cholestatic. In contrast, fluorescein was well transported, was partly glucuronidated, and had normal choleretic activity. NBD-tagged, but not amF-tagged, bile acids were actively transported by the intestine (ileum > jejunum), and no fluorescent bile acid had passive intestinal permeability; NBD-tagged bile acids were biotransformed during intestinal transport (jejunum > ileum). We conclude that the structure of the fluorophore as well as that of the bile acid influences transport by the hepatocyte and enterocyte. These fluorescent bile acids differ from fluorescein in being impermeable to cell membranes and undergoing little biotransformation during hepatocyte transport. Of these fluorescent bile acids, cholylglycylamF has hepatocyte transport and choleretic properties most closely resembling those of a natural bile acid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9362371     DOI: 10.1002/hep.510260526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Use of a fluorescent bile acid to enhance visualization of the biliary tract and bile leaks during laparoscopic surgery in rabbits.

Authors:  F Holzinger; L Krähenbühl; C D Schteingart; H T Ton-Nu; A F Hofmann
Journal:  Surg Endosc       Date:  2001-02       Impact factor: 4.584

Review 2.  Calcium signaling in the liver.

Authors:  Maria Jimena Amaya; Michael H Nathanson
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies.

Authors:  Dominique Debray; Dominique Rainteau; Véronique Barbu; Myriam Rouahi; Haquima El Mourabit; Stéphanie Lerondel; Colette Rey; Lydie Humbert; Dominique Wendum; Charles-Henry Cottart; Paul Dawson; Nicolas Chignard; Chantal Housset
Journal:  Gastroenterology       Date:  2012-02-24       Impact factor: 22.682

4.  Type 2 inositol 1,4,5-trisphosphate receptor modulates bile salt export pump activity in rat hepatocytes.

Authors:  Emma A Kruglov; Samir Gautam; Mateus T Guerra; Michael H Nathanson
Journal:  Hepatology       Date:  2011-08-30       Impact factor: 17.425

5.  Real-time intra-operative near-infrared fluorescence identification of the extrahepatic bile ducts using clinically available contrast agents.

Authors:  Aya Matsui; Eiichi Tanaka; Hak Soo Choi; Joshua H Winer; Vida Kianzad; Sylvain Gioux; Rita G Laurence; John V Frangioni
Journal:  Surgery       Date:  2010-02-01       Impact factor: 3.982

6.  Unusual binding of ursodeoxycholic acid to ileal bile acid binding protein: role in activation of FXRα.

Authors:  Changming Fang; Fabian V Filipp; Jeffrey W Smith
Journal:  J Lipid Res       Date:  2012-01-05       Impact factor: 5.922

7.  Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.

Authors:  Anand Balakrishnan; Stephen A Wring; Andrew Coop; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

Review 8.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target.

Authors:  Anand Balakrishnan; James E Polli
Journal:  Mol Pharm       Date:  2006 May-Jun       Impact factor: 4.939

9.  A continuous fluorescence assay for simple quantification of bile salt hydrolase activity in the gut microbiome.

Authors:  Kristoffer R Brandvold; Jacqueline M Weaver; Christopher Whidbey; Aaron T Wright
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.